A006620 Stock Overview
Manufactures and sells pharmaceuticals in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
DongKoo Bio & Pharma Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩5,010.00 |
| 52 Week High | ₩8,990.00 |
| 52 Week Low | ₩4,640.00 |
| Beta | 0.72 |
| 11 Month Change | -8.07% |
| 3 Month Change | -12.41% |
| 1 Year Change | -8.74% |
| 33 Year Change | -34.08% |
| 5 Year Change | 1.90% |
| Change since IPO | -60.96% |
Recent News & Updates
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%
Aug 23
Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?
Jul 25Recent updates
More Unpleasant Surprises Could Be In Store For DongKoo Bio & Pharma Co., Ltd.'s (KOSDAQ:006620) Shares After Tumbling 32%
Aug 23Should You Be Adding DongKoo Bio & Pharma (KOSDAQ:006620) To Your Watchlist Today?
Jul 25We Think That There Are Issues Underlying DongKoo Bio & Pharma's (KOSDAQ:006620) Earnings
Mar 27Shareholder Returns
| A006620 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 2.3% | -3.1% | 2.9% |
| 1Y | -8.7% | 4.8% | -2.8% |
Return vs Industry: A006620 underperformed the KR Pharmaceuticals industry which returned 4.8% over the past year.
Return vs Market: A006620 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A006620 volatility | |
|---|---|
| A006620 Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A006620 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A006620's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 375 | Cho Yong-Jun | www.dongkoo.com |
DongKoo Bio & Pharma Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company provides prescription drugs, such as antihistamines, dermatological oral medications, ophthalmic solutions, skeletal muscle relaxants, anti-inflammatory enzymes, antivirals, antibacterial agents, and for the treatment of allergies, liver diseases, mental illnesses, obesity, brain nervous, and endocrine systems; over-the-counter medicines, such as dermatological external preparations, antifungal agents, active probiotic intestinal supplements, antipyretic anti-inflammatory analgesics, and for the treatment of the respiratory, digestive, genitourinary, and circulatory systems; and quasi-drugs.
DongKoo Bio & Pharma Co., Ltd. Fundamentals Summary
| A006620 fundamental statistics | |
|---|---|
| Market cap | ₩136.78b |
| Earnings (TTM) | ₩13.00b |
| Revenue (TTM) | ₩240.39b |
10.5x
P/E Ratio0.6x
P/S RatioIs A006620 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A006620 income statement (TTM) | |
|---|---|
| Revenue | ₩240.39b |
| Cost of Revenue | ₩94.46b |
| Gross Profit | ₩145.93b |
| Other Expenses | ₩132.93b |
| Earnings | ₩13.00b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 476.33 |
| Gross Margin | 60.71% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 60.2% |
How did A006620 perform over the long term?
See historical performance and comparison